Toxicity profiles of immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta ‐analysis
ConclusionsOur study suggests that the incidences of grade three or more trAEs, treatment-related deaths, and trAEs leading to discontinuation of treatment are low in R/M HNSCC patients treated with ICIs. PD-L1 inhibitors monotherapy may be safer compared with PD-1 inhibitors monotherapy and ICIs combination therapy.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Shoutao Dang,
Xinyu Li,
Heshu Liu,
Shuyang Zhang,
Wei Li Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Head and Neck Cancer | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology